Literature DB >> 24656526

Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.

Abbey Jebb1, Peter Hadden2, Reuben J Broom3.   

Abstract

Entities:  

Keywords:  Paraneoplastic; tyrosine kinase inhibitor

Mesh：

Substances：

Year:  2014        PMID： 24656526     DOI： 10.1016/j.clgc.2014.02.002

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  1 in total

1.  Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.

Authors:  Yuze Cao; Xiaoyan Lu; Jianjian Wang; Huixue Zhang; Zhaojun Liu; Si Xu; Tianfeng Wang; Shangwei Ning; Bo Xiao; Lihua Wang
Journal:  Int J Mol Med       Date:  2017-01-11       Impact factor: 4.101
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.